Tolsura Capsule, Gelatin Coated
Product Images NDC 51862-462

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tolsura (NDC 51862-462). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Commercial Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tolsura 01)

FDA Label Image

Principal Display Panel (65 mg Capsule Bottle Label)

Principal Display Panel (65 mg Capsule Bottle Label)
Each capsule of Tolsura contains 65mg of itraconazole, a medication prescribed to treat fungal infections. The full prescribing information is available in the package insert. It should be kept out of the reach of children and stored between 15°C to 30°C (59°F to 86°F). It must be dispensed in a tight, light-resistant container. Tolsura is a patented product of Mayne Pharma and should not be confused with other itraconazole formulations produced by the same company. This drug is manufactured in Spain and distributed by Mayne Pharma in Greenville, NC. 60 capsules are included in the package.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.